Ilona Sztruhar

Title: Ilona Sztruhar: A Pioneering Inventor from Budapest

Introduction

Ilona Sztruhar is an innovative inventor based in Budapest, Hungary. With a focus on the pharmaceutical field, she has made significant contributions through her inventive strategies and methods, holding a total of two patents that showcase her expertise and dedication to advancing medical science

Latest Patents

Ilona Sztruhar's latest patents reflect her commitment to improving pharmaceutical processes. Her first patent details a process for the preparation of high-purity buspirone, which emphasizes the importance of continuously adding a solution of a specific compound to a suspension of a hydrogenation catalyst in an inert organic solvent. This invention enhances the purity of buspirone hydrochlorides. Additionally, she has developed an improved process for preparing 6,7-dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2[3H]-one, also known as anagrelide. This valuable blood platelet antiaggregative compound is produced via thermal cyclization in an acidic medium, allowing for industrial-scale manufacturing while overcoming issues present in previous methods.

Career Highlights

Throughout her career, Ilona has worked with prominent organizations such as Egis Gyógyszergyár and Egis Gyógyszergyár Rt. These companies have allowed her to refine her skills and contribute to the field of pharmaceuticals, significantly impacting drug production and processes.

Collaborations

Ilona has collaborated with notable individuals in her field, including colleagues Margit Csorgo and Jozsef Reiter. These partnerships have facilitated the exchange of ideas and advancements in the research and development of innovative pharmaceutical solutions.

Conclusion

Ilona Sztruhar's work exemplifies the spirit of innovation and dedication that defines successful inventors. Her contributions to the preparation of important pharmaceuticals not only benefit the medical community but also pave the way for future advancements in drug development. With her patents, she has cemented her place as a key figure in the evolution of pharmaceutical sciences.